Ellington Financial [EARN] vs Monroe Capital [MRCC] Detailed Stock Comparison
Ellington Financial
NYSE
Loading...
Monroe Capital
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 18 vital metrics comparison: Ellington Financial wins in 5 metrics, Monroe Capital wins in 13 metrics, with 0 ties. Monroe Capital appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Ellington Financial | Monroe Capital | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 20.39 | 83.00 | Ellington Financial |
| Price-to-Book Ratio | 0.94 | 0.90 | Monroe Capital |
| Debt-to-Equity Ratio | 226.91 | 116.14 | Monroe Capital |
| PEG Ratio | -0.09 | -0.52 | Monroe Capital |
| Profit Margin (TTM) | -14.61% | 3.74% | Monroe Capital |
| Operating Margin (TTM) | 75.59% | 72.81% | Ellington Financial |
| EBITDA Margin (TTM) | 75.59% | 72.81% | Ellington Financial |
| Return on Equity | -2.82% | 1.01% | Monroe Capital |
| Return on Assets (TTM) | -0.60% | 5.45% | Monroe Capital |
| Free Cash Flow (TTM) | $9.11M | $35.96M | Monroe Capital |
| Dividend Yield | 14.04% | 15.72% | Monroe Capital |
| 1-Year Return | -16.59% | -4.42% | Monroe Capital |
| Price-to-Sales Ratio (TTM) | 5.98 | 3.16 | Monroe Capital |
| Enterprise Value | $715.11M | $368.00M | Ellington Financial |
| EV/Revenue Ratio | 19.92 | 7.18 | Monroe Capital |
| Revenue per Share (TTM) | $1 | $2 | Monroe Capital |
| Earnings per Share (Diluted) | $0.28 | $0.09 | Ellington Financial |
| Beta (Stock Volatility) | 1.30 | 0.97 | Monroe Capital |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Ellington Financial vs Monroe Capital Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Ellington Financial | -0.35% | -3.40% | -0.87% | 1.25% | -10.83% | -14.84% |
| Monroe Capital | -0.26% | 1.75% | 21.94% | 19.62% | -7.13% | -12.40% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Ellington Financial | -16.59% | -27.46% | -49.38% | -56.77% | -70.99% | -70.99% |
| Monroe Capital | -4.42% | -11.27% | 0.00% | -48.75% | -50.07% | -50.07% |
Performance & Financial Health Analysis: Ellington Financial vs Monroe Capital
| Metric | EARN | MRCC |
|---|---|---|
| Market Information | ||
| Market Cap | $214.46M | $184.60M |
| Market Cap Category | Micro cap | Micro cap |
| 10 Day Avg. Volume | 347,110 | 73,270 |
| 90 Day Avg. Volume | 390,077 | 119,557 |
| Last Close | $5.68 | $7.56 |
| 52 Week Range | $4.33 - $7.11 | $5.96 - $8.85 |
| % from 52W High | -20.11% | -14.58% |
| All-Time High | $19.85 (May 20, 2013) | $16.37 (Sep 05, 2016) |
| % from All-Time High | -71.39% | -53.82% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.34% | -0.37% |
| Quarterly Earnings Growth | -1.90% | -1.13% |
| Financial Health | ||
| Profit Margin (TTM) | -0.15% | 0.04% |
| Operating Margin (TTM) | 0.76% | 0.73% |
| Return on Equity (TTM) | -0.03% | 0.01% |
| Debt to Equity (MRQ) | 226.91 | 116.14 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $6.08 | $8.29 |
| Cash per Share (MRQ) | $0.48 | $0.11 |
| Operating Cash Flow (TTM) | $19.53M | $118.27M |
| Levered Free Cash Flow (TTM) | $6.59M | $11.17M |
| Dividends | ||
| Last 12-Month Dividend Yield | 14.04% | 15.72% |
| Last 12-Month Dividend | $0.80 | $1.00 |
Valuation & Enterprise Metrics Analysis: Ellington Financial vs Monroe Capital
| Metric | EARN | MRCC |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 20.39 | 83.00 |
| Forward P/E | 4.84 | 7.40 |
| PEG Ratio | -0.09 | -0.52 |
| Price to Sales (TTM) | 5.98 | 3.16 |
| Price to Book (MRQ) | 0.94 | 0.90 |
| Market Capitalization | ||
| Market Capitalization | $214.46M | $184.60M |
| Enterprise Value | $715.11M | $368.00M |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 19.92 | 7.18 |
| Enterprise to EBITDA | N/A | N/A |
| Risk & Other Metrics | ||
| Beta | 1.30 | 0.97 |
| Book Value per Share (MRQ) | $6.08 | $8.29 |
Financial Statements Comparison: Ellington Financial vs Monroe Capital
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | EARN | MRCC |
|---|---|---|
| Revenue/Sales | $-5.29M | $-568,000 |
| Cost of Goods Sold | N/A | N/A |
| Gross Profit | N/A | N/A |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | N/A | N/A |
| EBITDA | N/A | N/A |
| Pre-Tax Income | $-7.88M | $-1.91M |
| Income Tax | $-6,000 | $-43,000 |
| Net Income (Profit) | $-7.87M | $-1.87M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | EARN | MRCC |
|---|---|---|
| Cash & Equivalents | $17.38M | $6.46M |
| Total Current Assets | N/A | N/A |
| Total Current Liabilities | N/A | N/A |
| Long-Term Debt | N/A | $269.09M |
| Total Shareholders Equity | $228.50M | $186.88M |
| Retained Earnings | $-171.74M | $-110.86M |
| Property, Plant & Equipment | N/A | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | EARN | MRCC |
|---|---|---|
| Operating Cash Flow | $-7.20M | $-1.67M |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | $9.21M | $26.07M |
| Debt Repayment | N/A | $-49.10M |
| Common Stock Repurchase | $-979,000 | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | EARN | MRCC |
|---|---|---|
| Shares Short | 238,322 | 98,698 |
| Short Ratio | 0.61 | 0.75 |
| Short % of Float | 0.01% | 0.00% |
| Average Daily Volume (10 Day) | 347,110 | 73,270 |
| Average Daily Volume (90 Day) | 390,077 | 119,557 |
| Shares Outstanding | 29.65M | 21.67M |
| Float Shares | 37.05M | N/A |
| % Held by Insiders | 0.01% | 0.01% |
| % Held by Institutions | 0.13% | 0.17% |
Dividend Analysis & Yield Comparison: Ellington Financial vs Monroe Capital
| Metric | EARN | MRCC |
|---|---|---|
| Last 12-Month Dividend | $0.80 | $1.00 |
| Last 12-Month Dividend Yield | 14.04% | 15.72% |
| 3-Year Avg Annual Dividend | $0.85 | $1.00 |
| 3-Year Avg Dividend Yield | 1.18% | 3.30% |
| 3-Year Total Dividends | $2.56 | $3.00 |
| Ex-Dividend Date | Mar 31, 2025 | Jun 16, 2025 |